Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Teradata Corp
TDC
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
eBay
EBAY
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -37.30%90.76M | -16.28%115.67M | -11.97%122.09M | -1.10%546.28M | -9.99%124.67M | 4.26%144.76M | -1.79%138.16M | 3.25%138.69M | 3.66%552.35M | 2.74%138.51M |
Operating revenue | -37.30%90.76M | -16.28%115.67M | -11.97%122.09M | -1.10%546.28M | -9.99%124.67M | 4.26%144.76M | -1.79%138.16M | 3.25%138.69M | 3.66%552.35M | 2.74%138.51M |
Cost of revenue | -31.72%28.36M | -17.21%35.4M | -13.74%37.28M | -2.51%165.72M | -9.49%38.22M | -2.83%41.53M | -0.34%42.76M | 2.61%43.22M | 11.26%169.98M | 16.56%42.23M |
Gross profit | -39.54%62.41M | -15.86%80.27M | -11.17%84.81M | -0.47%380.55M | -10.21%86.45M | 7.41%103.23M | -2.43%95.4M | 3.55%95.47M | 0.60%382.37M | -2.34%96.28M |
Operating expense | -22.97%49.36M | -26.92%53.15M | -16.14%54.22M | 5.28%263.33M | -2.04%61.86M | 3.39%64.08M | 16.60%72.73M | 3.27%64.66M | 3.86%250.11M | 2.13%63.14M |
Selling and administrative expenses | 34.21%15.11M | -9.39%12.71M | 4.01%11.07M | 9.24%50.87M | 22.79%14.93M | 4.26%11.26M | 23.59%14.03M | -13.11%10.65M | -15.42%46.56M | -9.95%12.16M |
-General and administrative expense | 34.21%15.11M | -9.39%12.71M | 4.01%11.07M | 9.24%50.87M | 22.79%14.93M | 4.26%11.26M | 23.59%14.03M | -13.11%10.65M | -15.42%46.56M | -9.95%12.16M |
Depreciation amortization depletion | -35.16%34.25M | -31.11%40.44M | -20.12%43.15M | 4.38%212.46M | -7.96%46.93M | 3.21%52.82M | 15.05%58.7M | 7.25%54.02M | 9.57%203.55M | 5.50%50.98M |
-Depreciation and amortization | -35.16%34.25M | -31.11%40.44M | -20.12%43.15M | 4.38%212.46M | -7.96%46.93M | 3.21%52.82M | 15.05%58.7M | 7.25%54.02M | 9.57%203.55M | 5.50%50.98M |
Operating profit | -66.68%13.05M | 19.61%27.12M | -0.73%30.59M | -11.37%117.23M | -25.79%24.59M | 14.72%39.15M | -35.96%22.67M | 4.14%30.81M | -5.03%132.26M | -9.85%33.14M |
Net non-operating interest income expense | 87.19%-2.71M | 52.79%-9.88M | 41.68%-11.62M | -5.55%-82M | 1.84%-20.01M | -5.01%-21.15M | -10.64%-20.92M | -9.12%-19.92M | -1.71%-77.69M | -9.12%-20.39M |
Non-operating interest income | --14M | --8.55M | --7.29M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Non-operating interest expense | -21.00%16.71M | -11.93%18.43M | -5.07%18.91M | 5.55%82M | -1.84%20.01M | 5.01%21.15M | 10.64%20.92M | 9.12%19.92M | 1.71%77.69M | 9.12%20.39M |
Other net income (expense) | 913.17%312.82M | 5,485.11%221.28M | -1,013.71%-42.27M | 102.14%232.54M | 1,152.53%193.08M | -41.17%30.88M | -91.05%3.96M | 60.68%4.63M | 79.49%115.04M | -62.86%15.42M |
Gain on sale of security | 1,088.18%368.89M | 1,055,763.64%232.25M | ---4.1M | 369.57%219.03M | 1,123.27%187.8M | 15.69%31.05M | -100.48%-22K | ---- | 669.07%46.64M | 383,900.00%15.35M |
Earnings from equity interest | -36.68%328K | -98.68%61K | -98.75%17K | -76.42%6.58M | -80.66%82K | -98.00%518K | 234.40%4.62M | 704.14%1.36M | -41.03%27.89M | -98.83%424K |
Special income (charges) | ---32.56M | --2.95M | -963.08%-34.13M | -91.29%3.75M | --0 | --0 | --0 | 23.02%3.95M | 261.27%43.05M | -99.48%27K |
-Less:Impairment of capital assets | ---- | ---- | --66.6M | --0 | --0 | ---- | ---- | --0 | -65.12%2.54M | --0 |
-Less:Other special charges | --32.56M | ---277K | ---760K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Gain on sale of business | ---- | --2.67M | --0 | -91.78%3.75M | --0 | ---- | --0 | 11.71%3.75M | 137.59%45.58M | -99.48%27K |
-Gain on sale of property,plant,equipment | ---- | ---- | 15,370.24%31.71M | ---- | ---- | ---- | ---- | 244.37%205K | ---- | ---- |
Other non- operating income (expenses) | -3,356.09%-23.85M | -2,103.63%-13.97M | -491.41%-4.06M | 225.55%3.19M | 1,440.21%5.2M | -37.72%-690K | 44.73%-634K | -36.31%-687K | -114.35%-2.54M | -1,437.93%-388K |
Income before tax | 561.14%323.15M | 4,073.68%238.53M | -250.18%-23.3M | 57.87%267.77M | 601.71%197.66M | -26.47%48.88M | -90.59%5.72M | 9.21%15.52M | 33.59%169.61M | -52.73%28.17M |
Income tax | -15.68%199K | -22.38%281K | 18.31%252K | 150.61%2.05M | 2,725.53%1.23M | -8.53%236K | 2.55%362K | -15.48%213K | -47.35%816K | -109.53%-47K |
Net income | 563.94%322.95M | 4,350.68%238.25M | -253.91%-23.55M | 57.43%265.72M | 596.17%196.42M | -26.54%48.64M | -91.14%5.35M | 9.65%15.3M | 34.59%168.79M | -52.25%28.22M |
Net income continuous Operations | 563.94%322.95M | 4,350.68%238.25M | -253.91%-23.55M | 57.43%265.72M | 596.17%196.42M | -26.54%48.64M | -91.14%5.35M | 9.65%15.3M | 34.59%168.79M | -52.25%28.22M |
Minority interest income | 0 | 0 | -75.34%18K | 0 | 0 | 0.00%18K | -84.82%73K | -81.44%18K | ||
Net income attributable to the parent company | 563.94%322.95M | 4,350.68%238.25M | -254.10%-23.55M | 57.48%265.7M | 596.61%196.42M | -26.52%48.64M | -91.14%5.35M | 9.66%15.28M | 35.05%168.72M | -52.20%28.2M |
Preferred stock dividends | 0.00%2.79M | 0.00%2.79M | 0.00%2.79M | 0.00%11.16M | 0.00%2.79M | 0.00%2.79M | 0.00%2.79M | 0.00%2.79M | -18.31%11.16M | 0.00%2.79M |
Other preferred stock dividends | 1,071.00%1.17M | 56.82%138K | 22.43%131K | 25.21%606K | 168.10%311K | -14.53%100K | -29.60%88K | -15.08%107K | -91.55%484K | -4.92%116K |
Net income attributable to common stockholders | 597.21%318.99M | 9,403.96%235.32M | -313.69%-26.47M | 61.66%253.94M | 664.37%193.32M | -27.71%45.75M | -95.69%2.48M | 12.39%12.39M | 48.82%157.08M | -54.90%25.29M |
Basic earnings per share | 600.00%6.09 | 11,100.00%4.48 | -316.67%-0.52 | 63.51%4.84 | 666.67%3.68 | -27.50%0.87 | -96.30%0.04 | 20.00%0.24 | 45.10%2.96 | -55.56%0.48 |
Diluted earnings per share | 597.70%6.07 | 11,000.00%4.44 | -316.67%-0.52 | 65.75%4.84 | 666.67%3.68 | -27.50%0.87 | -96.30%0.04 | 20.00%0.24 | 43.14%2.92 | -53.85%0.48 |
Dividend per share | 0 | 0.00%0.52 | 0.00%0.52 | 0.00%2.08 | 0.00%0.52 | 0.00%0.52 | 0.00%0.52 | 0.00%0.52 | 10.64%2.08 | 8.33%0.52 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |